The management of diabetes in hospital is complicated!
It is influenced by...
Currently, when patients present with complex disease and poorly controlled diabetes, the typical response by most care teams is to use a subcutaneous "sliding scale insulin" (SSI) regimen, hoping that this will address the patient's changing:
However, SSI therapy alone results in costly, and most importantly, unsafe, blood glucose control for the patient.
Clinical evidence supports the use of BBIT as a safer and more clinically versatile alternative. In spite of this evidence, the use of SSI in hospital has persisted, leading to the question of how do we change?
Summary & Guidelines